Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sarcoma
|
42 | 0.581 | 0.520 | 7 | 55181378 | missense variant | C/T | snv | 2.8E-05 | 5.6E-05 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Secondary malignant neoplasm of bone
|
18 | 0.581 | 0.520 | 7 | 55181378 | missense variant | C/T | snv | 2.8E-05 | 5.6E-05 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Secondary malignant neoplasm of lung
|
20 | 0.581 | 0.520 | 7 | 55181378 | missense variant | C/T | snv | 2.8E-05 | 5.6E-05 | 0.010 | 1.000 | 1 | 2020 | 2020 | ||||
Secondary malignant neoplasm of lymph node
|
188 | 0.581 | 0.520 | 7 | 55181378 | missense variant | C/T | snv | 2.8E-05 | 5.6E-05 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Signs and Symptoms, Respiratory
|
10 | 0.581 | 0.520 | 7 | 55181378 | missense variant | C/T | snv | 2.8E-05 | 5.6E-05 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Squamous cell carcinoma of the head and neck
|
348 | 0.581 | 0.520 | 7 | 55181378 | missense variant | C/T | snv | 2.8E-05 | 5.6E-05 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Squamous cell carcinoma, keratinizing
|
1 | 0.581 | 0.520 | 7 | 55181378 | missense variant | C/T | snv | 2.8E-05 | 5.6E-05 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
stage, non-small cell lung cancer
|
6 | 0.581 | 0.520 | 7 | 55181378 | missense variant | C/T | snv | 2.8E-05 | 5.6E-05 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Thymoma
|
20 | 0.581 | 0.520 | 7 | 55181378 | missense variant | C/T | snv | 2.8E-05 | 5.6E-05 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Tumor Angiogenesis
|
5 | 0.581 | 0.520 | 7 | 55181378 | missense variant | C/T | snv | 2.8E-05 | 5.6E-05 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Breast Carcinoma
|
2793 | 0.581 | 0.520 | 7 | 55181378 | missense variant | C/T | snv | 2.8E-05 | 5.6E-05 | 0.020 | 1.000 | 2 | 2013 | 2015 | ||||
Carcinoma, Small Cell
|
7 | 0.581 | 0.520 | 7 | 55181378 | missense variant | C/T | snv | 2.8E-05 | 5.6E-05 | 0.020 | 1.000 | 2 | 2013 | 2017 | ||||
Colorectal Carcinoma
|
1962 | 0.581 | 0.520 | 7 | 55181378 | missense variant | C/T | snv | 2.8E-05 | 5.6E-05 | 0.020 | 1.000 | 2 | 2018 | 2019 | ||||
Familial (FPAH)
|
276 | 0.581 | 0.520 | 7 | 55181378 | missense variant | C/T | snv | 2.8E-05 | 5.6E-05 | 0.020 | 1.000 | 2 | 2014 | 2014 | ||||
Malignant neoplasm of breast
|
3417 | 0.581 | 0.520 | 7 | 55181378 | missense variant | C/T | snv | 2.8E-05 | 5.6E-05 | 0.020 | 1.000 | 2 | 2013 | 2015 | ||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.581 | 0.520 | 7 | 55181378 | missense variant | C/T | snv | 2.8E-05 | 5.6E-05 | 0.020 | 1.000 | 2 | 2018 | 2019 | ||||
melanoma
|
515 | 0.581 | 0.520 | 7 | 55181378 | missense variant | C/T | snv | 2.8E-05 | 5.6E-05 | 0.020 | 1.000 | 2 | 2018 | 2019 | ||||
Meningeal Carcinomatosis
|
1 | 0.581 | 0.520 | 7 | 55181378 | missense variant | C/T | snv | 2.8E-05 | 5.6E-05 | 0.020 | 1.000 | 2 | 2013 | 2017 | ||||
Refractory cancer
|
9 | 0.581 | 0.520 | 7 | 55181378 | missense variant | C/T | snv | 2.8E-05 | 5.6E-05 | 0.020 | 1.000 | 2 | 2009 | 2013 | ||||
Secondary malignant neoplasm of liver
|
34 | 0.581 | 0.520 | 7 | 55181378 | missense variant | C/T | snv | 2.8E-05 | 5.6E-05 | 0.020 | 1.000 | 2 | 2017 | 2019 | ||||
Tumor Cell Invasion
|
169 | 0.581 | 0.520 | 7 | 55181378 | missense variant | C/T | snv | 2.8E-05 | 5.6E-05 | 0.020 | 0.500 | 2 | 2013 | 2016 | ||||
Metastatic Lung Adenocarcinoma
|
10 | 0.581 | 0.520 | 7 | 55181378 | missense variant | C/T | snv | 2.8E-05 | 5.6E-05 | 0.030 | 1.000 | 3 | 2011 | 2018 | ||||
Non-small cell lung cancer recurrent
|
4 | 0.581 | 0.520 | 7 | 55181378 | missense variant | C/T | snv | 2.8E-05 | 5.6E-05 | 0.030 | 1.000 | 3 | 2011 | 2016 | ||||
Secondary Neoplasm
|
85 | 0.581 | 0.520 | 7 | 55181378 | missense variant | C/T | snv | 2.8E-05 | 5.6E-05 | 0.030 | 1.000 | 3 | 2014 | 2018 | ||||
Squamous cell carcinoma
|
257 | 0.581 | 0.520 | 7 | 55181378 | missense variant | C/T | snv | 2.8E-05 | 5.6E-05 | 0.030 | 0.667 | 3 | 2011 | 2016 |